Aerie Pharmaceuticals

+$0.37 (+2.89%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AERI and other ETFs, options, and stocks.

About AERI

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105.

CEO
Vicente J. Anido, Jr., PhD
Employees
365
Headquarters
Durham, North Carolina
Founded
2005

AERI Key Statistics

Market Cap
621.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
631.77K
High Today
$13.29
Low Today
$12.71
Open Price
$12.76
Volume
210.31K
52 Week High
$21.30
52 Week Low
$9.01

AERI Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure